Conduit Pharmaceuticals Receives Patent Approval for Its Lead Asset Targeting Autoimmune Diseases
Conduit藥品已獲得針對自身免疫性疾病的主要資產專利批准
Conduit Pharmaceuticals Receives Patent Approval for Its Lead Asset Targeting Autoimmune Diseases
Conduit藥品已獲得針對自身免疫性疾病的主要資產專利批准
譯文內容由第三人軟體翻譯。